TITLE

Therapeutic Scope of Intravenous Nitroglycerin

AUTHOR(S)
Flaherty, John T.
PUB. DATE
May 1982
SOURCE
Angiology;May1982, Vol. 33 Issue 5, p287
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Sublingual nitroglycerin has been the time-honored therapy for angina pectoris for nearly a century. Sustained-action oral forms and cutaneous ointment have been used for perhaps ten years for prophylactic treatment of angina and even more recently have been recommended for use in congestive failure. For the past six years investigators at Johns Hopkins Hospital have been administering intravenous nitroglycerin to patients with acute myocardial infarction with and without left ventricular failure. More recently, we have employed intravenous nitroglycerin to manage acute hypertension developing in patients before and after coronary artery bypass graft surgery. I would like to review with you the current indications for intravenous nitroglycerin and the beneficial effects that would be expected in each clinical situation. I will draw on our own clinical experience obtained in nearly 200 patients1-6 and, when necessary, on the recent medical literature.
ACCESSION #
16406667

 

Related Articles

  • Recurrent myocardial infarction secondary to Prinzmetal's variant angina. Dhillon, Priyanka; Murdoch, Dale; Niranjan, Selvanayagam // Singapore Medical Journal;May2015, Vol. 56 Issue 5, pe74 

    Prinzmetal's variant angina describes chest pain secondary to reversible coronary artery vasospasm in the context of both diseased and non-diseased coronary arteries. Symptoms typically occur when the patient is at rest and are associated with transient ST-segment elevation. Acute episodes...

  • Unstable Angina Pectoris. Yeghiazarians, Yerem; Braunstein, Joel B.; Askari, Arman; Stone, Peter H. // New England Journal of Medicine;01/13/2000, Vol. 342 Issue 2, p101 

    Focuses on the pathophysiology and management of unstable angina and distinguishes it from non-Q-wave myocardial infarction when possible and appropriate. Details of pathogenesis; Medical therapy used to treat unstable angina; Risk stratification and selection of management strategies

  • CME-Labor 27/Auflösung. Hornemann, Thorsten // Praxis (16618157);10/17/2012, Vol. 101 Issue 20, p1338 

    No abstract available.

  • Chest pain: 3 case reports.  // Reactions Weekly;5/29/2004, Issue 1003, p7 

    Discusses research being done on the link between capecitabine and severe angina pectoris-like chest pain. Reference to a study by H. Boot et al, published in the March 16, 2004 issue of "Annals of Internal Medicine"; Effect of the discontinuation of capacitabine intake on patients who had...

  • Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcets syndrome. S. Ugurlu; E. Seyahi; H. Yazici // Rheumatology;Apr2008, Vol. 47 Issue 4, p472 

    Objective. To determine the risk of clinical cardiovascular disease in middle-aged patients with Behcets syndrome (BS) compared with gender-matched non-BS subjects. Methods. The prevalence of angina, myocardial infarction (MI), doctor diagnosed ischaemic heart disease (IHD) and intermittent...

  • retrosternal pain. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p662 

    An encyclopedia entry for "retrosternal pain" is presented. It refers to pain in the chest's central region, behind the sternum. Among its causes are irritation of the oesophagus, angina pectoris or myocardial infarction.

  • unstable angina. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p770 

    Am encyclopedia entry for "unstable angina" is presented. This is referred to as a form of angina pectoris that develops during sleep or without provocation, or a condition that is becoming more frequent or severe. Also noted is the high risk of myocardial infarction from this condition leading...

  • Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial. Sani, Hashem Danesh; Eshraghi, Ali; Nezafati, Mohammad Hassan; Vojdanparast, Mohammad; Shahri, Bahram; Nezafati, Pouya // Journal of Cardiovascular Pharmacology & Therapeutics;Jul2015, Vol. 20 Issue 4, p401 

    Objective: Patients with the coronary slow flow phenomenon frequently experience angina episodes. The present study aimed to compare the efficacy of nicorandil versus nitroglycerin for alleviation of angina symptoms in slow flow patients. Methods: In a single-center, single-blind,...

  • EFFECT OF SUSTAINED RELEASE NITROGLYCERIN CAPSULES ON ANGINAL FREQUENCY AND EXERCISE CAPACITY: A DOUBLE-BLIND EVALUATION. Davidov, Michael E.; Mroczek, William J. // Angiology;Mar1977, Vol. 28 Issue 3, p181 

    Examines the therapeutic effectiveness of sustained release nutroglycerin preparation administered orally to patients with classic angina pectoris. Approaches to a prolonged pharmacologic action of nitroglycerin; Comparison between sustained release nitroglycerin preparation and placebo capsule.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics